On-Demand Catalog

All sessions average between 60 and 90 minutes.

Regulation of Cannabis in FDA-Regulated Products
The EU’s New Medical Device and IVD Regulations
REMS: Key Issues and Best Practices
Compounding Still in the Mix: Title I of the DQSA, the Compounding Quality Act, Three Years Later
False Claims Act Enforcement
Recent FDA Guidance Documents on Manufacturer Communications about Medical Products
21st Century Cures Act
The Yates Memo: A Lawyer’s Professional Responsibility
Social Media: Innovative Uses and Practical Experiences
Mandatory GMO Labeling: Preparing for Implementation

Filter Results